Carlyle (CGABL) Cash & Equivalents (2011 - 2026)

Carlyle has reported Cash & Equivalents for 16 years, with the latest figure at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 40.57% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 40.57% YoY), and the FY2025 full-year result was $2.0 billion, up 55.62% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $1.7 billion, down from $2.0 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $2.2 billion in Q3 2025, with the low at $870.3 million in Q2 2023.
• Average Cash & Equivalents over 5 years is $1.4 billion, with a median of $1.3 billion recorded in 2022.
• Year-over-year, Cash & Equivalents plunged 44.9% in 2022 and soared 61.37% in 2025.
• Tracing CGABL's Cash & Equivalents over 5 years: stood at $1.4 billion in 2022, then advanced by 5.85% to $1.4 billion in 2023, then declined by 12.1% to $1.3 billion in 2024, then soared by 55.62% to $2.0 billion in 2025, then declined by 15.07% to $1.7 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.7 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.

Peer Comparison